Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.

Prostate cancer is the second most frequently diagnosed cancer in men. Metabolomics can potentially provide new insights into the aetiology of prostate cancer by identifying new metabolic risk factors. This study investigated the prospective association between plasma metabolite concentrations and p...

Full description

Bibliographic Details
Published in:BMC Medicine
Main Authors: Röhnisch, Hanna E, Kyrø, Cecilie, Olsen, Anja, Thysell, Elin, Hallmans, Göran, Moazzami, Ali A
Format: Article in Journal/Newspaper
Language:English
Published: BioMed Central 2020
Subjects:
Mass spectrometry
Metabolomics
Nested case-control study
Nuclear magnetic resonance spectroscopy
Prostate cancer
Risk biomarkers
Northern Sweden
Online Access:https://doi.org/10.1186/s12916-020-01655-1
https://pubmed.ncbi.nlm.nih.gov/32698845
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376662/
id ftpubmed:32698845
record_format openpolar
spelling ftpubmed:32698845 2024-09-15T18:26:04+00:00 Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study. Röhnisch, Hanna E Kyrø, Cecilie Olsen, Anja Thysell, Elin Hallmans, Göran Moazzami, Ali A 2020-07-23 https://doi.org/10.1186/s12916-020-01655-1 https://pubmed.ncbi.nlm.nih.gov/32698845 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376662/ eng eng BioMed Central https://doi.org/10.1186/s12916-020-01655-1 https://pubmed.ncbi.nlm.nih.gov/32698845 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376662/ BMC Med ISSN:1741-7015 Volume:18 Issue:1 Mass spectrometry Metabolomics Nested case-control study Nuclear magnetic resonance spectroscopy Prostate cancer Risk biomarkers Journal Article Research Support, Non-U.S. Gov't 2020 ftpubmed https://doi.org/10.1186/s12916-020-01655-1 2024-07-31T16:03:00Z Prostate cancer is the second most frequently diagnosed cancer in men. Metabolomics can potentially provide new insights into the aetiology of prostate cancer by identifying new metabolic risk factors. This study investigated the prospective association between plasma metabolite concentrations and prostate cancer risk, both overall and by stratifying for disease aggressiveness and baseline age. Article in Journal/Newspaper Northern Sweden PubMed Central (PMC) BMC Medicine 18 1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Mass spectrometry
Metabolomics
Nested case-control study
Nuclear magnetic resonance spectroscopy
Prostate cancer
Risk biomarkers
spellingShingle Mass spectrometry
Metabolomics
Nested case-control study
Nuclear magnetic resonance spectroscopy
Prostate cancer
Risk biomarkers
Röhnisch, Hanna E
Kyrø, Cecilie
Olsen, Anja
Thysell, Elin
Hallmans, Göran
Moazzami, Ali A
Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
topic_facet Mass spectrometry
Metabolomics
Nested case-control study
Nuclear magnetic resonance spectroscopy
Prostate cancer
Risk biomarkers
description Prostate cancer is the second most frequently diagnosed cancer in men. Metabolomics can potentially provide new insights into the aetiology of prostate cancer by identifying new metabolic risk factors. This study investigated the prospective association between plasma metabolite concentrations and prostate cancer risk, both overall and by stratifying for disease aggressiveness and baseline age.
format Article in Journal/Newspaper
author Röhnisch, Hanna E
Kyrø, Cecilie
Olsen, Anja
Thysell, Elin
Hallmans, Göran
Moazzami, Ali A
author_facet Röhnisch, Hanna E
Kyrø, Cecilie
Olsen, Anja
Thysell, Elin
Hallmans, Göran
Moazzami, Ali A
author_sort Röhnisch, Hanna E
title Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
title_short Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
title_full Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
title_fullStr Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
title_full_unstemmed Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
title_sort identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the northern sweden health and disease study.
publisher BioMed Central
publishDate 2020
url https://doi.org/10.1186/s12916-020-01655-1
https://pubmed.ncbi.nlm.nih.gov/32698845
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376662/
genre Northern Sweden
genre_facet Northern Sweden
op_source BMC Med
ISSN:1741-7015
Volume:18
Issue:1
op_relation https://doi.org/10.1186/s12916-020-01655-1
https://pubmed.ncbi.nlm.nih.gov/32698845
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376662/
op_doi https://doi.org/10.1186/s12916-020-01655-1
container_title BMC Medicine
container_volume 18
container_issue 1
_version_ 1810466514851069952

Similar Items